Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolaemia: A comparison of morning and evening administration

European Journal of Clinical Pharmacology

Volumn 49, Issue 5, 1996, Pages 361-364

  Nozaki, S ^a   Nakagawa, T ^a   Nakata, A ^a   Yamashita, S ^a   Kameda Takemura, K ^a   Nakamura, T ^a   Keno, Y ^a   Tokunaga, K ^a   Matsuzawa, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cholesterol synthesis; Circadian rhythm; Hypercholesterolaemia; Mevalonate; Pravastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HETEROZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0030028479     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00203778     Document Type: Article

References (17)

1. Edwards PA, Muroya H, Gould RG (1972) In vivo demonstration of the circadian rhythm of cholesterol synthesis in a liver and intestine of the rat. J Lipid Res 13:396-401
2. Ho KJ (1979) Circadian rhythm of cholesterol biosynthesis: dietary regulation in the liver and small intestine of hamsters. Int J Chronobiol 6:39-50
3. Jones PJH, Schoeller DA (1990) Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res 31:667-673
4. Parker, TS, McNamara DJ, Brown C, Garngan O, Kolb R, Batwin H, Ahrens EH Jr (1982) Mevalonic acid in human plasma: relationship of concentration and circadian rhythm to cholesterol synthesis rate in man. Proc Natl Acad Sci USA 79:3037-3041
5. Popjak G, Boehm G, Parker TS, Edmond J, Eduards PA, Fogelman AM (1979) Determination of mevalonate in blood plasma in man and rat. Mevalonate "tolerance" tests in man. J Lipid Res 20:716-728
6. Parker TS, McNamara DJ, Brown CD, Kolb R, Ahrens EH Jr (1984) Plasma mevalonate as a measure of cholesterol synthesis in man. J Clin Invest 74:795-804
7. Kempen HJM, Glatz JFC, Leuven JAG, van der Voort HA, Katan MB (1989) Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 29:1149-1155
8. Miettinen TA (1982) Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 23:466-473
9. Miettinen TA (1985) Cholesterol precursors and their diurnal rhythm in lipoproteins of patients with jejunoileal bypass and ileal dysfunction. Metabolism 34:425-430
10. Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S (1991) Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism 40:741-746
11. Nozaki S, Kubo M, Sudo H, Matsuzawa Y, Tarui S (1986) The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein-postheparin lipolytic activities determined by a sensitive, non-radioisotopic method in hyperlipidemic patients and normals. Metabolism 35:53-58
12. Nakura K, Imada I, Sato K, Sakota K, Kawakami M (1992) An improved assay for mevalonic acid in blood (in Japanese). Igaku to Yakugaku 27:939-945
13. Jones PJH, Papue AS, Illingworth DR, Leith CA (1992) Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis. Eur J Clin Invest 22, 609-613
14. Pappu AS, Illingworth DR, Bacon S (1989) Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acids by lovastatin in patients with heterozygous familial hypercholesterolemia. Metabolism 38:542-549
15. Illingworlh DR (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40:338-343
16. The Lovastatin Study Group IV (1990) A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. Am J Cardiol 66:22B-30B
17. Nakaya N, Kuta T, Matsuzawa Y, Saito Y, Nakai T, Yamamoto A, Goto Y (1990) Clinical study of pravastatin (CS-514) at once-daily dosage in hyperlipidemia double-blind comparative study between morning and evening therapy (in Japanese). Rinsyo Iyaku 6:1804-1828